Presentations

First Day

Eberhard Schatz – Welcomepdf

Introduction Session

Beatrice Stambul – MARSEILLE, UNE HISTOIRE DE LA RÉDUCTION DES RISQUESpdf
Freek Spinnewijn – Health & Homelessnesspdf
Joachim Levy – Early identification, screening and health pathways for young adults in extreme precariousness pdf
JP Grund – Overdose Prevention Status Quo, Challenges & New Technology Based Solutionspdf
Perrine Roux – Safe injection education : experiencespdf

Panel Discussion

Danièle Bader – SCMR et réduction des risquespdf
Marseille Declarationpdf
Marta Pinto – Health related consequences of criminalization for People Who Use Psychoactive Substancespdf

Session 1

D. Hedrich – Promoting access of PWID to HCV testing and care through harm reduction service providerspdf
E.Schatz – Good Practice Examplespdf
Flavie Oster – SCREEN, EVALUATE, TREAT HEP C IN FRENCH DRUG CONSUMPTION ROOMpdf
Jan Kozák – Good practice in Czech Republicpdf
John’s Gibbons –  Groundswell supporting people affected by homelessness to attend health appointmentspdf
Marie Francis – Peer supported HCV models of care. Results from the HepCare project.pdf
Raquel Glória – COMPARISON OF TWO PROXIMITY BASED MODELS OF CARE TO INCREASE HCV TREATMENT ADHERENCE AMONG P WUDpdf

Session 2

Telma Azevedo – Infectious diseases appointments inside correctional facilities: experience from a Portuguese Centrepdf
Paschalis Vavelidis – Access4all in Prisonspdf

Session 3

Ole Jorgent – Hepatitis bus A Norwegian drug user iniative pdf
Oli Wehrli – Arud Hep C Peer to Peer Projectpdf

Session 4

Caren Magen – EUROSIDER PROJECT Preliminary resultspdf
Laelia Briand – pdf

Session 5

Simona Ciobanu – The gap between treatment and people living with Hepatitis C –barriers and opportunitiespdf

Session 6

JP Grund – Overdose Prevention Status Quo, Challenges and New Technology Based Solutionspdf

Session 7

Elias Phiri – HCV Screening in London Borough of Waltham Forest, Londonpdf
Moro Yapha – Outreach, peer work and the challenge to prevent infection diseases under undocumented
migrants at Görlitzer Park, Berlinpdf
Denis Onyango – HCV and (Un)documented Migrants Access to Health and HCV Preventionpdf

Session 8

RIchard Stranz
EurosiderTraining for ITSESI interventions. Building capacity to support PWIDpdf

 

Second Day

 

Dr Andrew Ustianowski – ENGLAND & GREATER MANCHESTER HCV ELIMINATION PLANSpdf
Dr Antons Mozalevskis – WHO recommen d ations on viral hepatitis in people who use drugs and people in prisonspdf
Dagmar Hedrich – EMCDDA HepC Initiative and Elimination Barometer for PWIDpdf
Leon Wylie – Hepatitis Scotlandpdf
Hélène Delaquaize – De la maladie chronique à la maladie curable :
le combat de la société civile en France pour rendre le traitement accessiblepdf